A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
This report contains market size and forecasts of Generic Drugs in Global, including the following market information:
Global Generic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Generic Drugs market was valued at 322540 million in 2021 and is projected to reach US$ 550750 million by 2028, at a CAGR of 7.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prescription Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Generic Drugs include Teva, Novartis – Sandoz, Mylan, Sun Pharmaceutical, Aspen, Fresenius Kabi, Pfizer (Hospira), Sanofi and Aurobindo, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Generic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Generic Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Generic Drugs Market Segment Percentages, by Type, 2021 (%)
Prescription
Non-Prescription Drugs
Global Generic Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Generic Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Generic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Generic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Generic Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Generic Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Novartis – Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy’s
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Pharmaniaga Berhad
Hovid Berhad
Duopharma Biotech
Kotra Pharma
HOE Pharmaceutical
Y.S.P. Industries

LEAVE A REPLY

Please enter your comment!
Please enter your name here